ES2157567T3 - Derivados de aminoacidos enantiomericos que tienen efecto anticonvulsivo. - Google Patents
Derivados de aminoacidos enantiomericos que tienen efecto anticonvulsivo.Info
- Publication number
- ES2157567T3 ES2157567T3 ES97916897T ES97916897T ES2157567T3 ES 2157567 T3 ES2157567 T3 ES 2157567T3 ES 97916897 T ES97916897 T ES 97916897T ES 97916897 T ES97916897 T ES 97916897T ES 2157567 T3 ES2157567 T3 ES 2157567T3
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- amino acids
- enantiomeric amino
- anticonvulsive effect
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UN COMPUESTO DE CONFIGURACION R RESPECTO AL CARBONO ASIMETRICO DE LA FORMULA (I), SIENDO AR FENILO, EL CUAL ESTA SIN SUSTITUIR O SUSTITUIDO CON AL MENOS UN GRUPO HALO; Q ES UN GRUPO ALCOXI INFERIOR, Y Q 1 ES METILO. SE PRESENTAN ASIMISMO COMPOSICIONES FARMACEUTICAS QUE CONTIENEN DICHOS DERIVADOS Y LA UTILIZACION DE LAS MISMAS PARA EL TRATAMIENTO DE ALTERACIONES DEL SISTEMA NERVIOSO CENTRAL (SNC) EN ANIMALES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1352296P | 1996-03-15 | 1996-03-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2157567T3 true ES2157567T3 (es) | 2001-08-16 |
Family
ID=21760388
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97916897T Expired - Lifetime ES2157567T3 (es) | 1996-03-15 | 1997-03-17 | Derivados de aminoacidos enantiomericos que tienen efecto anticonvulsivo. |
ES00109377T Expired - Lifetime ES2218024T3 (es) | 1996-03-15 | 1997-03-17 | Derivados de aminoacido enantiomerico anticonvulsionante. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES00109377T Expired - Lifetime ES2218024T3 (es) | 1996-03-15 | 1997-03-17 | Derivados de aminoacido enantiomerico anticonvulsionante. |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP1038522B1 (es) |
JP (1) | JP3145414B2 (es) |
AT (2) | ATE202079T1 (es) |
AU (1) | AU718577B2 (es) |
CA (1) | CA2248317C (es) |
DE (3) | DE122009000010I2 (es) |
DK (2) | DK0888289T3 (es) |
ES (2) | ES2157567T3 (es) |
FR (1) | FR09C0006I2 (es) |
NL (1) | NL300376I1 (es) |
PT (2) | PT1038522E (es) |
WO (1) | WO1997033861A1 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048899A (en) * | 1997-03-17 | 2000-04-11 | Research Corporation Tech., Inc. | Anticonvulsant enantiomeric amino acid derivatives |
EP1642889A1 (en) * | 2004-10-02 | 2006-04-05 | Schwarz Pharma Ag | Improved synthesis scheme for lacosamide |
EP1873527A1 (en) | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Method for identifying CRMP modulators |
US8093426B2 (en) * | 2007-12-04 | 2012-01-10 | Ranbaxy Laboratories Limited | Intermediate compounds and their use in preparation of lacosamide |
DE102008059155A1 (de) | 2008-11-27 | 2010-06-02 | Ratiopharm Gmbh | Trockenverarbeitung und neue Formen von Lacosamid |
EP2462107A1 (en) | 2009-08-06 | 2012-06-13 | Medichem, S.A. | Solid forms of an n-(phenylmethyl)propanamide derivative and processes of preparation |
JP5564570B2 (ja) * | 2009-09-25 | 2014-07-30 | カディラ・ヘルスケア・リミテッド | ラコサミドおよびその中間体の調製方法 |
IT1398044B1 (it) * | 2010-01-29 | 2013-02-07 | Archimica Srl | Processo per la preparazione della lacosamide |
EP2534128A1 (en) | 2010-02-08 | 2012-12-19 | Natco Pharma Limited | A process for the preparation of lacosamide |
WO2011099033A1 (en) * | 2010-02-09 | 2011-08-18 | Msn Laboratories Limited | Process for preparing (r)-2-acetamido-n-benzyl-3-methoxy-propionamide |
EP2399901A1 (en) | 2010-06-23 | 2011-12-28 | Archimica GmbH | Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide |
EP2621893A1 (en) | 2010-10-01 | 2013-08-07 | UCB Pharma GmbH | Process for the preparation of amino acid derivatives |
EP2627639B1 (en) * | 2010-10-15 | 2021-12-22 | Nektar Therapeutics | N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides |
EP2444390B1 (en) | 2010-10-19 | 2017-02-01 | Euticals GmbH | Process for producing Lacosamide |
EP2468261A1 (en) | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation of lacosamide |
US20130251813A1 (en) | 2010-12-02 | 2013-09-26 | Ucb Pharma Gmbh | Formulation of lacosamide |
CN104771356A (zh) * | 2014-01-09 | 2015-07-15 | 山东方明药业集团股份有限公司 | 一种拉科酰胺注射液及其制备方法 |
US11278634B1 (en) | 2021-02-12 | 2022-03-22 | Extrovis Ag | Stable parenteral composition of lacosamide |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378729A (en) * | 1985-02-15 | 1995-01-03 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
ATE62222T1 (de) * | 1985-02-15 | 1991-04-15 | Res Corp Technologies Inc | Aminosaeure-derivate und ihre anwendung zur herstellung eines antikrampfmittels. |
-
1997
- 1997-03-17 DK DK97916897T patent/DK0888289T3/da active
- 1997-03-17 AT AT97916897T patent/ATE202079T1/de active
- 1997-03-17 AT AT00109377T patent/ATE268169T1/de active
- 1997-03-17 AU AU25394/97A patent/AU718577B2/en not_active Expired
- 1997-03-17 CA CA002248317A patent/CA2248317C/en not_active Expired - Lifetime
- 1997-03-17 ES ES97916897T patent/ES2157567T3/es not_active Expired - Lifetime
- 1997-03-17 DE DE122009000010C patent/DE122009000010I2/de active Active
- 1997-03-17 ES ES00109377T patent/ES2218024T3/es not_active Expired - Lifetime
- 1997-03-17 PT PT00109377T patent/PT1038522E/pt unknown
- 1997-03-17 WO PCT/US1997/004579 patent/WO1997033861A1/en active IP Right Grant
- 1997-03-17 DE DE69729392T patent/DE69729392T2/de not_active Expired - Lifetime
- 1997-03-17 PT PT97916897T patent/PT888289E/pt unknown
- 1997-03-17 EP EP00109377A patent/EP1038522B1/en not_active Expired - Lifetime
- 1997-03-17 DE DE69705210T patent/DE69705210T2/de not_active Expired - Lifetime
- 1997-03-17 DK DK00109377T patent/DK1038522T3/da active
- 1997-03-17 JP JP53292897A patent/JP3145414B2/ja not_active Expired - Lifetime
- 1997-03-17 EP EP97916897A patent/EP0888289B1/en not_active Expired - Lifetime
-
2009
- 2009-02-16 NL NL300376C patent/NL300376I1/nl unknown
- 2009-02-26 FR FR09C0006C patent/FR09C0006I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
EP1038522B1 (en) | 2004-06-02 |
DE122009000010I2 (de) | 2010-10-21 |
EP1038522A3 (en) | 2003-01-15 |
AU718577B2 (en) | 2000-04-13 |
DE69729392D1 (de) | 2004-07-08 |
DK1038522T3 (da) | 2004-10-11 |
EP1038522A2 (en) | 2000-09-27 |
PT888289E (pt) | 2001-09-28 |
EP0888289A1 (en) | 1999-01-07 |
ATE268169T1 (de) | 2004-06-15 |
DE69705210T2 (de) | 2001-09-20 |
DK0888289T3 (da) | 2001-09-03 |
CA2248317A1 (en) | 1997-09-18 |
AU2539497A (en) | 1997-10-01 |
DE69705210D1 (de) | 2001-07-19 |
FR09C0006I1 (es) | 2009-04-17 |
PT1038522E (pt) | 2004-10-29 |
EP0888289B1 (en) | 2001-06-13 |
JP2000505476A (ja) | 2000-05-09 |
FR09C0006I2 (fr) | 2009-12-18 |
JP3145414B2 (ja) | 2001-03-12 |
NL300376I1 (nl) | 2009-05-06 |
ATE202079T1 (de) | 2001-06-15 |
DE122009000010I1 (de) | 2009-05-20 |
CA2248317C (en) | 2003-12-02 |
WO1997033861A1 (en) | 1997-09-18 |
ES2218024T3 (es) | 2004-11-16 |
DE69729392T2 (de) | 2005-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300376I1 (nl) | Enantiomere anticonvulsieaminozuurderivaten | |
BR9810841A (pt) | Inibidores de metaloprotease alicìclicos | |
ATE168007T1 (de) | Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole | |
BR9808281A (pt) | Compostos, composições farmacêuticas, processo para tratar doenças proliferativas e/ou distúrbios do sistema imune e para preparar um composto, e, uso de um composto | |
BR9804352A (pt) | Composição e processo para controlar o crescimento microbiológico. | |
EA199900620A1 (ru) | Фталазиноны | |
DK0699439T3 (da) | Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer | |
DE69229442T2 (de) | Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung | |
ES2180564T3 (es) | 2-fenil-3-azoilbenzotiofenos para aumentar la expresion de trombomodulina. | |
ES552348A0 (es) | Procedimiento de preparar agentes anticonvulsivos derivados de aminoacidos | |
ATE156359T1 (de) | Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis | |
ATE194912T1 (de) | Mittel zur vorsorge und heilung von typ i allergischen krankheiten | |
ATE264104T1 (de) | Immunmodulierende arzneimittelzusammenstellung | |
ES2058085T3 (es) | Composicion anticonvulsivante que contiene un derivado de aminoacido, y utilizacion de dicho derivado de aminoacido. | |
ES2191763T3 (es) | Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico. | |
EA199900888A1 (ru) | Противоревматические средства | |
BR9813775A (pt) | Uso de um composto, processo para o tratamento de uma condição de cefaléia vascular, e, composição farmacêutica adequada para uso no tratamento de uma condição de cefaléia vascular. | |
ATE283269T1 (de) | 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems | |
BR9900024A (pt) | Biciclo[3.1.0]hexanos e compostos relacionados. | |
DK0810223T3 (da) | Adamantylsubstituerede oxindoler som farmaceutiske midler | |
EA200101043A1 (ru) | Способ лечения неврологических или нейропсихиатрических расстройств | |
TH20641A (th) | 6-[ไทรแอโซลิล[3-(ไทรฟลูออโรเมธิล)เฟนิล]เมธิล]-2-ควิโนลิโนนและ-ควิโนลีนไธโอน | |
HUP9902191A2 (hu) | Az érképződést gátló anyag |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 888289 Country of ref document: ES |